AgraFlora Organics Provides Guidance and Facility Expansion Updates at Toronto, ON Brewhouse; Increases Production Capacities by 30%
Ryan Allway
June 25th, 2019
News
VANCOUVER, British Columbia, June 25, 2019 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (PU31.F) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to provide the following operational guidance and retrofit updates pertaining to its ongoing facility expansion initiatives at the Brunswick Bierworks’ facility (the “Brewhouse”), located in Toronto, Ontario:
- Increase of annual production capacities to over 130,000 hectolitres (“hl”);
- 30% increase over previous maximum volume capacity;
- By comparison, Canadian brewer Steam Whistle Brewing produces approximately 95,000 hl on an annualized basis;
- Access to additional off-site contingent brewing capacity;
- Installation of dedicated cannabinoid-infused beverage packaging line equipped with four, six and 12 can capabilities;
- Customized to incorporate AgraFlora’s patented pharmaceutical-grade dispensing cap technology and advanced cannabinoid delivery mechanisms designed to protect volatile ingredients such as cannabinoids, antibiotics, probiotics, vitamins and minerals resulting in superior shelf stability for infused bottled beverages;
- Product formulation and batch testing projected to commence in fiscal Q3 2019;
- Developed by a roster of brew masters to better replicate the profile of traditional alcoholic beverages;
- Forecasted commercial production scheduled for fiscal Q4 2019, corresponding with proposed Health Canada regulations;
- Planned development of an adjoined, dedicated cannabinoid-infused beverage tasting and viewing facility; and,
- Ongoing retrofit and required licensing of existing, on-site captive research, development and testing facility.
By way of an exclusive partnership agreement with prominent Canadian brewing collective Brunswick Bierworks, AgraFlora holds claim to the exclusive formulation, manufacturing and distribution rights for all cannabinoid-infused beverages developed at Brunswick’s Toronto, Ontario Brewhouse. Equipped with custom production equipment, captive research, development and testing facilities, as well as established brewing infrastructure, the Brewhouse now boasts annual output capacity capabilities in excess of 130,000 hl.
AgraFlora and Brunswick Bierworks continue to aggressively pursue expansion activities at its state of the art Brewhouse. Upon completion of the facility retrofit and planned expansion initiatives, aggregate capital expenditures deployed on the Brewhouse will exceed C$20 million. Composed of a consortium of experienced brewery partners, the Brewhouse has completed multiple production runs for prominent European beverage brands, such as:
- Guinness;
- Augustiner; and,
- Innes & Gunn.
Proprietary brewing processes and associated technologies firmly position the Brewhouse at the forefront of non-alcoholic, cannabinoid-infused beverage development. This partnership positions AgraFlora at the forefront of the Canadian cannabis beverage industry, affording the Company preeminent exposure to a collective of domestic and global brewery partners, as well as further crystallizes a leading production platform for the company’s carbonated beverage product offering, including:
- Non-alcoholic beers;
- Seltzers; and,
- Ready-to-drink (“RTDs”) beverages.
Brandon Boddy, Chairman and Chief Executive Officer of AgraFlora stated: “AgraFlora’s exclusive partnership with Brunswick Bierworks further bolsters the Company’s position as Canada’s premier cannabinoid-infused beverage consolidation platform. With Canada’s planned legalization of cannabis edibles/beverages later this year, AgraFlora had the corporate foresight to enter the cannabis beverage market early on, thus solidifying the brewing infrastructure, supplier relationships and product formulations required to achieve significant market share.
Augmented by Brunswick Bierworks’ proprietary brewing processes and best in class facility, we expect to bring to Canadian consumers cannabinoid-infused beverages that address the major issues currently limiting appeal of this category in other markets, a beverage that 1) actually tastes good and 2) provides an immediate and controllable cannabis experience.
This is the most opportune time to be a first mover within the adult-format beverage market vertical, further substantiated by the pending legalization of cannabis-infused edibles, which prohibits the combination of cannabis and alcohol.”
The Brewhouse has also secured additional capacity for packaged products to be brewed off-site. Complementary off-site capacity augurs well for AgraFlora’s mission to retain a first-mover advantage within the cannabinoid-infused beverage marketplace.
Additionally, AgraFlora and Brunswick are finalizing the installation of a dedicated cannabinoid-infused beverage packaging line; with four, six and 12 can capabilities- customized to incorporate AgraFlora’s patented pharmaceutical-grade dispensing cap technology and advanced cannabinoid delivery mechanisms. Designed to protect volatile ingredients such as cannabinoids, antibiotics, probiotics, vitamins and minerals, the Company’s pharmaceutical-grade dispensing cap technology has shown to promote superior shelf stability for infused bottled beverages.
Together, these retrofit initiatives coupled with planned follow-on Brewhouse enhancements and operational modernizations represent a multi-million dollar capital investment that will usher in a new age in world-class carbonated beverage formulation, production and packaging.
AgraFlora is also pleased to announce the launch of the company’s redesigned website, which can be viewed on-line at https://www.agraflora.com/. The Company encourages all current and potential shareholders to visit the website and explore AgraFlora recently completed rebranding and redesign initiatives.
About AgraFlora Organics International Inc.
AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It owns an indoor cultivation operation in London, ON and is a joint venture partner in Propagation Service Canada and its large-scale 2,200,000 sq. ft. greenhouse complex in Delta, BC. The Company has a successful record of creating shareholder value and is actively pursuing other opportunities within the cannabis industry. For more information please visit: www.agraflora.com.
AgraFlora Organics International Inc. (CNW Group/AgraFlora Organics International Inc.)
ON BEHALF OF THE BOARD OF DIRECTORS
Brandon Boddy
Chairman & CEO
T: (604) 682-2928
| For additional information:
AgraFlora Organics International Inc. |
For French inquiries: |
The CSE and Information Service Provider have not reviewed and does not accept responsibility for the accuracy or adequacy of this release.
Forward-looking Information Cautionary Statement
Except for statements of historic fact, this news release contains certain “forward-looking information” within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as “plan”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate” and other similar words, or statements that certain events or conditions “may” or “will” occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Company’s control. There are no assurances that the business plans for AgraFlora Organics described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company’s filings with Canadian securities regulators, which are available at www.sedar.com.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Alan Brochstein’s 420 Investor is the go-to community for investors to learn, explore, and profit from the marijuana companies. The main goal of 420 Investor is to provide real-time, objective information about the top marijuana companies in the market in order to help investors capitalize on cannabis.
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
True Leaf is a Licensed Producer of cannabis preparing to launch a program to provide seed-to-shelf solutions for micro-cultivators.
Ovation Science Inc. is a research and development company that develops topical and transdermal consumer products including its CBD/THC cannabis formulations including ARLO CBD Beauty and InVibe® MD (“health & wellness” line), and secondly, its unique DermSafe® hand sanitizer; all made with its patented Invisicare® skin delivery technology.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
